Projecting the long‐term societal value of a disease‐modifying treatment for Alzheimer's disease in the United States

INTRODUCTION: We estimate societal value of a disease‐modifying Alzheimer's disease (AD) treatment that reduces progression by 30% in early stages. METHODS: Using the International Society for Pharmacoeconomics and Outcomes Research value flower as framework, we estimate gross societal value, t...

Descripción completa

Detalles Bibliográficos
Autores principales: Prados, Maria J., Liu, Ying, Jun, Hankyung, Lam, Jenny, Mattke, Soeren
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Featured Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9303743/
https://www.ncbi.nlm.nih.gov/pubmed/35142025
http://dx.doi.org/10.1002/alz.12578

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9303743/
https://www.ncbi.nlm.nih.gov/pubmed/35142025
http://dx.doi.org/10.1002/alz.12578

Ejemplares similares